Other News To Note
RegeneRx Biopharmaceuticals Inc., of Rockville, Md., said researchers have shown that Thymosin beta 4 provided both neuroprotection and neurorestoration in a rat model of traumatic brain injury. Compared with placebo, the drug, initiated six hours post-injury, statistically significantly improved sensorimotor functional recovery and spatial learning, reduced cortical lesion volume and hippocampal cell loss.
Suite: 1100 | Atlanta, Georgia 30346, USA
Outside of the US
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
Sign up for Highlights FREE e-mail newsletter